GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » YoY EBITDA Growth

Cessatech AS (FRA:8GN) YoY EBITDA Growth : -44.68% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cessatech AS YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cessatech AS's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -44.68%.

Cessatech AS's EBITDA per Share for the three months ended in Dec. 2024 was €-0.07.

Cessatech AS YoY EBITDA Growth Historical Data

The historical data trend for Cessatech AS's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS YoY EBITDA Growth Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
- - -9.54 34.23 32.42

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.69 41.07 31.67 86.27 -44.68

Cessatech AS YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cessatech AS's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.148--0.219)/ | -0.219 |
=32.42 %

Cessatech AS's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.068--0.047)/ | -0.047 |
=-44.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cessatech AS YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cessatech AS's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (FRA:8GN) » Definitions » YoY EBITDA Growth
Comparable Companies
OSTO:IVACC OSTO:LIPUM OSTO:ISOFOL OSTO:ACE OSTO:XBRANE OSTO:IRLAB A OSTO:INIT OSTO:XINT OSTO:GUARD OSTO:IMMU VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CESSA:Sweden
Address
Strandvejen 60, Hellerup, DNK, DK- 2900
Website
https://www.cessatech.com
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines